Latest Breaking News On - United kingdom haematology lead at roche products - Page 1 : comparemela.com

The new therapy, known as glofitamab or Columvi®, has been approved by both the Medicines and Healthcare Products Regulatory Agency (MHRA) and the National Institute of Health and Care Excellence

United kingdomWendy osbornePeter clarkAmanda pritchardJohn sharpPia ballschmieterHelen knightUnited kingdom national health serviceNational institute of healthHealthcare products regulatory agencyEngland cancer drug fundUnited kingdom haematology lead at roche productsCancer drugs fundNational health serviceNational instituteCare excellence